Drug intelligence / Profile preview

syzygium heyneanum extract

Development stage
Preclinical
Administration
Oral
01

Overview

Syzygium heyneanum extract (SHE) is a botanical extract derived from the plant *Syzygium heyneanum*, currently being investigated as a preclinical research compound for its potential neuroprotective effects in Parkinson's disease. Rich in antioxidant polyphenols and flavonoids, the extract has demonstrated the ability to mitigate neuroinflammation and oxidative stress in paraquat-induced rat models. Its mechanism of action involves the modulation of key biomarkers associated with neurodegeneration, including the reduction of α-synuclein expression, inhibition of acetylcholinesterase (AChE) activity, and suppression of pro-inflammatory cytokines such as TNF-α, IL-1β, and IL-6. While SHE shows promise in academic studies for restoring antioxidant enzyme levels and improving behavioral symptoms, it is not currently in formal pharmaceutical development by any commercial sponsor.

Other names
Syzygium heyneanum ethanol extractSHE
02

Targets

SNCA (Alpha-synuclein)TNFA (Tumor necrosis factor alpha (soluble))AcetylcholinesteraseIL-6 (Interleukin 6)IL1B (Interleukin-1 beta)

Beyond the preview

Go deeper on syzygium heyneanum extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on syzygium heyneanum extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call